Tetsuya Higuchi Selected Research

(4-fluoro-3-iodobenzyl)guanidine

1/2018

Radiolabeled (4-Fluoro-3-Iodobenzyl)Guanidine Improves Imaging and Targeted Radionuclide Therapy of Norepinephrine Transporter-Expressing Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuya Higuchi Research Topics

Disease

56	Neoplasms (Cancer) 01/2022 - 05/2002
9	Pheochromocytoma 03/2022 - 06/2008
8	Squamous Cell Carcinoma of Head and Neck 08/2021 - 06/2005
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 10/2004
6	Paraganglioma (Paragangliomas) 03/2022 - 06/2008
6	Hypoxia (Hypoxemia) 02/2020 - 12/2006
6	Lung Neoplasms (Lung Cancer) 01/2020 - 09/2003
4	Neoplasm Metastasis (Metastasis) 01/2016 - 06/2008
3	Lymphoma (Lymphomas) 08/2022 - 08/2006
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2014
3	Neuroblastoma 01/2021 - 02/2015
3	Thyroid Neoplasms (Thyroid Cancer) 04/2020 - 12/2014
3	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 02/2014
3	Glioma (Gliomas) 12/2017 - 07/2003
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2015 - 01/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2021 - 05/2004
2	Hemorrhage 01/2021 - 01/2015
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2021
2	Allergic Contact Dermatitis 01/2021 - 09/2017
2	Siderosis 01/2021 - 01/2015
2	Adenoma (Adenomas) 07/2017 - 06/2015
2	Inflammation (Inflammations) 07/2015 - 05/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2009 - 07/2005
2	Cholangiocarcinoma 02/2008 - 01/2008
2	Hepatocellular Carcinoma (Hepatoma) 01/2008 - 12/2007
2	Autoimmune Diseases (Autoimmune Disease) 05/2004 - 01/2002
1	Glioblastoma (Glioblastoma Multiforme) 08/2022
1	Pseudolymphoma 01/2022
1	Ulcer 07/2021
1	Neuroinflammatory Diseases 01/2021
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Craniopharyngioma (Craniopharyngiomas) 01/2021
1	Cerebral Hemorrhage 01/2021

Drug/Important Bio-Agent (IBA)

23	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 07/2003
12	Amino Acids FDA Link 01/2020 - 06/2013
11	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2004
10	Deoxyglucose (2 Deoxy D glucose)IBA 01/2016 - 02/2004
7	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021 - 01/2008
7	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 10/2010
6	3-Iodobenzylguanidine (Iobenguane)IBA 03/2022 - 06/2008
6	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019 - 03/2009
5	IodineIBA 04/2020 - 07/2011
5	Monoclonal AntibodiesIBA 10/2016 - 07/2003
4	HexokinaseIBA 01/2021 - 06/2005
4	CD40 Ligand (CD40L)IBA 01/2014 - 01/2002
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
3	Therapeutic UsesIBA 01/2018 - 01/2014
2	Cetuximab (Erbitux)FDA Link 08/2021 - 10/2019
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 09/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 06/2020 - 10/2016
2	Cadherins (E-Cadherin)IBA 01/2020 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 10/2019 - 07/2003
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2019 - 07/2009
2	Biological ProductsIBA 06/2019 - 01/2015
2	AntigensIBA 02/2019 - 01/2014
2	Fluorine-18IBA 11/2018 - 12/2017
2	Radioisotopes (Radionuclides)IBA 01/2018 - 01/2016
2	NivolumabIBA 01/2018 - 10/2016
2	FluorineIBA 01/2018 - 01/2018
2	alpha-Methyltyrosine (Metirosine)FDA Link 12/2014 - 02/2007
2	Indium-111IBA 03/2014 - 07/2009
2	Yttrium-90IBA 08/2012 - 07/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 03/2009
2	Choline (Choline Chloride)IBA 07/2004 - 02/2004
1	IsotopesIBA 08/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Probenecid (Benemid)FDA LinkGeneric 01/2022
1	Organic Anion TransportersIBA 01/2022
1	VX (EDIM)IBA 08/2021
1	SteroidsIBA 07/2021
1	benzylguanidineIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	THK5351IBA 01/2021
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	Thyroglobulin FDA Link 04/2020
1	Pyruvate KinaseIBA 02/2020
1	IsoenzymesIBA 02/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020
1	Valosin Containing ProteinIBA 01/2020
1	ThymineIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020

Therapy/Procedure

16	Therapeutics 03/2022 - 06/2004
5	Drug Therapy (Chemotherapy) 12/2016 - 10/2004
5	Radiotherapy 07/2015 - 04/2006
4	Radioimmunotherapy 08/2012 - 07/2005
2	Renal Dialysis (Hemodialysis) 01/2019 - 02/2016
2	Chemoradiotherapy 12/2014 - 02/2014
2	Injections 08/2012 - 06/2006
2	Aftercare (After-Treatment) 02/2010 - 07/2009
2	Gamma Cameras (Gamma Camera) 09/2003 - 07/2003
1	Ostomy 07/2021
1	Thyroidectomy 04/2020